Cargando…

Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography

Spectral-domain optical coherence tomography (SD-OCT) represents a reliable tool for retinal layer volume and thickness measurement. The aim of this study was to evaluate retinal changes indicating neurodegenerative processes in patients with end-stage renal disease (ESRD) compared to healthy contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Susanne, Bosch, Agnes, Ott, Christian, Kannenkeril, Dennis, Dienemann, Thomas, Harazny, Joanna M., Michelson, Georg, Schmieder, Roland E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093533/
https://www.ncbi.nlm.nih.gov/pubmed/32210247
http://dx.doi.org/10.1038/s41598-020-61308-4
_version_ 1783510302472536064
author Jung, Susanne
Bosch, Agnes
Ott, Christian
Kannenkeril, Dennis
Dienemann, Thomas
Harazny, Joanna M.
Michelson, Georg
Schmieder, Roland E.
author_facet Jung, Susanne
Bosch, Agnes
Ott, Christian
Kannenkeril, Dennis
Dienemann, Thomas
Harazny, Joanna M.
Michelson, Georg
Schmieder, Roland E.
author_sort Jung, Susanne
collection PubMed
description Spectral-domain optical coherence tomography (SD-OCT) represents a reliable tool for retinal layer volume and thickness measurement. The aim of this study was to evaluate retinal changes indicating neurodegenerative processes in patients with end-stage renal disease (ESRD) compared to healthy controls. This was a cross-sectional, single-center study comprising 32 ESRD patients and 38 controls. Sectoral retinal nerve fiber layer (RNFL) thickness and retinal layer volumes were obtained by SD-OCT. Age- and gender-adjusted retinal layer volumes such as total retinal volume (p = 0.037), ganglion cell layer volume (GCL, p = 0.003), ganglion cell layer – inner plexiform layer volume (GCL-IPL, p = 0.005) and inner retinal layer volume (IRL, p = 0.042) of the right eye were lower in ESRD patients. Inner plexiform layer volume of both eyes (IPL, right eye: p = 0.017; left eye: 0.044) was reduced, as was RNFL thickness in the temporal superior sector (right eye: p = 0.016). A subgroup analysis excluding patients with diabetes revealed that GCL (p = 0.014) and GCL-IPL volume of the right eye (p = 0.024) and temporal superior sector of the RNFL scan (p = 0.021) in ESRD patients were still significantly thinner. We observed a decrease in several retinal layer volumes and temporal RNFL thickness indicative of retinal neurodegenerative processes in patients with ESRD.
format Online
Article
Text
id pubmed-7093533
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70935332020-03-27 Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography Jung, Susanne Bosch, Agnes Ott, Christian Kannenkeril, Dennis Dienemann, Thomas Harazny, Joanna M. Michelson, Georg Schmieder, Roland E. Sci Rep Article Spectral-domain optical coherence tomography (SD-OCT) represents a reliable tool for retinal layer volume and thickness measurement. The aim of this study was to evaluate retinal changes indicating neurodegenerative processes in patients with end-stage renal disease (ESRD) compared to healthy controls. This was a cross-sectional, single-center study comprising 32 ESRD patients and 38 controls. Sectoral retinal nerve fiber layer (RNFL) thickness and retinal layer volumes were obtained by SD-OCT. Age- and gender-adjusted retinal layer volumes such as total retinal volume (p = 0.037), ganglion cell layer volume (GCL, p = 0.003), ganglion cell layer – inner plexiform layer volume (GCL-IPL, p = 0.005) and inner retinal layer volume (IRL, p = 0.042) of the right eye were lower in ESRD patients. Inner plexiform layer volume of both eyes (IPL, right eye: p = 0.017; left eye: 0.044) was reduced, as was RNFL thickness in the temporal superior sector (right eye: p = 0.016). A subgroup analysis excluding patients with diabetes revealed that GCL (p = 0.014) and GCL-IPL volume of the right eye (p = 0.024) and temporal superior sector of the RNFL scan (p = 0.021) in ESRD patients were still significantly thinner. We observed a decrease in several retinal layer volumes and temporal RNFL thickness indicative of retinal neurodegenerative processes in patients with ESRD. Nature Publishing Group UK 2020-03-24 /pmc/articles/PMC7093533/ /pubmed/32210247 http://dx.doi.org/10.1038/s41598-020-61308-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Jung, Susanne
Bosch, Agnes
Ott, Christian
Kannenkeril, Dennis
Dienemann, Thomas
Harazny, Joanna M.
Michelson, Georg
Schmieder, Roland E.
Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
title Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
title_full Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
title_fullStr Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
title_full_unstemmed Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
title_short Retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
title_sort retinal neurodegeneration in patients with end-stage renal disease assessed by spectral-domain optical coherence tomography
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093533/
https://www.ncbi.nlm.nih.gov/pubmed/32210247
http://dx.doi.org/10.1038/s41598-020-61308-4
work_keys_str_mv AT jungsusanne retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT boschagnes retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT ottchristian retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT kannenkerildennis retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT dienemannthomas retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT haraznyjoannam retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT michelsongeorg retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography
AT schmiederrolande retinalneurodegenerationinpatientswithendstagerenaldiseaseassessedbyspectraldomainopticalcoherencetomography